Correlation Between Morgan Stanley and Arcadia Biosciences

Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and Arcadia Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and Arcadia Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Morgan Stanley Direct and Arcadia Biosciences, you can compare the effects of market volatilities on Morgan Stanley and Arcadia Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of Arcadia Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and Arcadia Biosciences.

Diversification Opportunities for Morgan Stanley and Arcadia Biosciences

0.35

Correlation Coefficient

Morgan Stanley  Arcadia Biosciences

Weak diversification

The 3 months correlation between Morgan and Arcadia is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and Arcadia Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcadia Biosciences and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with Arcadia Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcadia Biosciences has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and Arcadia Biosciences go up and down completely randomly.

Pair Corralation between Morgan Stanley and Arcadia Biosciences

Given the investment horizon of 90 days Morgan Stanley is expected to generate 14.73 times less return on investment than Arcadia Biosciences. But when comparing it to its historical volatility, Morgan Stanley Direct is 15.15 times less risky than Arcadia Biosciences. It trades about 0.14 of its potential returns per unit of risk. Arcadia Biosciences is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  289.00  in Arcadia Biosciences on September 15, 2024 and sell it today you would earn a total of  341.00  from holding Arcadia Biosciences or generate 117.99% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Morgan Stanley Direct  vs.  Arcadia Biosciences

Morgan Stanley Direct

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley Direct are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating fundamental indicators, Morgan Stanley may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Arcadia Biosciences

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Arcadia Biosciences are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile fundamental indicators, Arcadia Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Morgan Stanley and Arcadia Biosciences

The main advantage of trading using opposite Morgan Stanley and Arcadia Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, Arcadia Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcadia Biosciences will offset losses from the drop in Arcadia Biosciences' long position.

The idea behind Morgan Stanley Direct and Arcadia Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.